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Introduction
Pyoderma gangrenosum (PG) is an uncommon, idiopathic
ulcerative neutrophilic inflammatory skin disease character-
ized by variable clinical presentation, and the cause of this
disease is uncertain [1]. Diagnosis of pyoderma gangreno-
sum is clinical, and histopathology is not specific and
depends on exclusion of other causes of cutaneous ulcera-
tion [2]. Clinically it starts with sterile pustules that rapidly
progress and become painful ulcers of different size with
violaceous borders. The legs are most commonly affected,
but other parts of the skin and mucous membranes may also
be involved [3].
PG commonly occurs between 25 and 54 years of age
and occurs rarely in children. The estimated incidence of PG
is approximately 3–10 patients per 1,000,000 population per
year [4].
Approximately 50 % of patients have an associated sys-
temic disease, commonly inflammatory bowel disease
(IBD), ulcerative colitis, arthritis, hematological and lym-
phoreticular malignancies, while in another 40–50 %
patients, no underlying disease is found. The disease is
recurrent in approximately 30 % of patients [5, 6]. The
management of PG is treatment of underlying systemic
medical illness and judicious use of immunosuppressants.
Case report
A 24-year-old male patient presented with a sudden visual
loss which started a few hours earlier in his left eye. His
medical history revealed PG for the last 3 years. He was on
treatment with cyclosporin A (2×150 mg) and deflazacort
(1× 30 mg) for maintenance therapy of PG. In his ophthal-
mologic examination, visual acuity was 20/25 OD and 20/
1200 OS. Slit lamp examination was unremarkable except
bilateral mild posterior subcapsular cataracts. Intraocular
pressures, pupil examination and extraocular muscle move-
ments were normal in both eyes. Fundus examination of the
right eye showed healthy retina, vitreous, optic nerve head
and retinal vasculature, and left eye showed large preretinal,
intraretinal and subretinal hemorrhages involving the inferi-
or part of the macula, inferior temporal arcade, nasal and
superior parts of retina and edema at the optic nerve head.
Vascular changes included significantly increased tortuosity
and diffuse perivascular sheathing (Fig. 1). There was no
vitritis. Fundus fluorescein angiogram (FFA) of left eye
revealed delayed filling of peripheral vessels, late staining
of vessels and optic nerve head together with some capillary
non-perfusion areas and blocked fluorescence in hemor-
rhagic areas (Fig. 2). FFA of right eye was normal.
The patient was evaluated for tuberculosis with PPD and
chest X-ray, syphilis with VDRL, sarcoidosis with chest X-
ray and serum and urine calcium levels, Behcet’s disease
with pathergy test, spondyloarthropathies with HLA-B27,
SLE and other collagen vascular disorders, IBD and pro-
thrombotic conditions. All of the tests and examinations
were negative for these diseases. The patient was assessed
as retinal vasculitis due to PG. The dose of deflazacort
which is a steroid was increased to 60 mg by his dermatol-
ogist after the tests. The hemorrhages started to decrease at
the third week visit and totally resolved within 6 months.
N. Yuksel (*)
Department of Ophthalmology, Kahramanmaras State Hospital,




Department of Ophthalmology, Gazi University Medical School,
Ankara, Turkey
J Ophthal Inflamm Infect (2012) 2:239–241
DOI 10.1007/s12348-012-0083-9
Steroid dose was decreased to a maintenance dose of 10 mg/
day. Visual acuity in left eye increased to 20/25 at the eighth
month and started to decrease thereafter because of the
posterior subcapsular cataracts to become 20/50 at the last
visit. At the 18th month follow-up, fundus evaluation
revealed only some vitreous opacity inferiorly without any
vascular finding in the left eye (Fig. 3).
Discussion
Pyoderma gangrenosum is an uncommon chronic ulcerative
condition, the etiology of which is poorly understood [7].
Common disease associations are inflammatory bowel
disease, arthritis, monoclonal gammopathy, leukemia, im-
mune deficiency state and HIV infection [5, 6].
Systemic steroids and cyclosporine A either alone or in
combination are considered to be the first line of treatment
[8]. Other agents used include dapsone, clofazimine, thalid-
omide, azathioprine and mycophenolate mofetil [9].
Ophthalmic findings associated with PG are rare [7]. PG-
associated nodular scleritis [10], orbital inflammation [10],
eyelid involvements [11–13] and peripheral ulcerative ker-
atitis [14] have been reported. In the vast majority of cases,
immunosuppressive therapy had been successful.
Despite immunosuppressive therapy with prednisolone and
cyclosporine A, a case with destruction of the orbital contents
with subsequent perforation of the eye went evisceration [7].
Evisceration was performed together with hyperbaric oxygen
therapy pre- and postoperatively. Hyperbaric oxygen therapy
helps to reverse the impaired neutrophil function and pro-
motes fibroblasts to produce collagen [7].
Our patient's history consisted of chest, face and lower
extremity papules that eventually ulcerated for 3 years,
diagnosed PG based on the clinical aspects of the skin
lesions, after exclusion of other specific ulcerative pro-
cesses by his dermatologists. Histopathology of the
lesions was unspecific (chronic ulcer), and he had no
systemic disease associated. After ocular involvement oc-
curred, detailed investigation was made for differential
diagnosis of retinal vasculitis. Clinical and laboratory
tests were negative for other systemic diseases; thereafter,
diagnosis was assessed as retinal vasculitis due to PG.
The only PG case associated with retinal vasculitis in the
literature was a 49-year-old man who had some other bilat-
eral ocular findings like limbal neovascularization, corneal
thinning, extensive gutter formation at the corneal/scleral
margin and corneal ulcerations [15]. Immunosuppressive
Fig. 1 Fundus photograph of the left eye at presentation. Left eye
showed large preretinal, intraretinal and subretinal hemorrhages in-
volving the inferior part of the macula, inferior temporal arcade, nasal
and superior parts of retina and edema at the optic nerve head. Vascular
changes included significantly increased tortuosity and diffuse peri-
vascular sheathing
Fig. 2 FFA of left eye revealed some capillary non-perfusion areas and
blocked fluorescence in hemorrhagic areas
Fig. 3 At the 18th month visit, the left fundus was almost normal
except from some vitreous opacity inferiorly without any vascular
finding
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therapy with prednisolone 10 mg daily, dapsone 100 mg
daily, minocycline 100 mg daily and topical betamethasone
did well in this particular case.
Conclusion
In conclusion, in the absence of other common causes of
retinal vasculitis, we presume that in this case the retinal
vasculitis is being caused by PG which responds well to
systemic steroid therapy. Early recognition of the manifes-
tations can lead to the institution of appropriate therapy,
thereby improving the patient's prognosis.
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